SOST and prostate cancer: In addition, we also show that the expression of the Wnt inhibitor Sost is significantly down-regulated in osteoblasts co-cultured with prostate cancer cells, strongly suggesting that in addition to modulating bone metabolism, Sost may also play a role in cancer–bone interaction potentially facilitating cancer metastasis to bone.